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One of the requirements for tumor growth is the ability to recruit a blood supply, a process known as angiogenesis. Angiogenesis begins early in
the progression of cervical disease from mild to severe dysplasia and on to invasive cancer. We have previously reported that expression of human
papillomavirus type 16 E6 and E7 (HPV16 E6E7) proteins in primary foreskin keratinocytes (HFKs) decreases expression of two inhibitors and
increases expression of two angiogenic inducers [Toussaint-Smith, E., Donner, D.B., Roman, A., 2004. Expression of human papillomavirus type
16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 23, 2988–2995].
Here we report that HPV-induced early changes in the keratinocyte phenotype are sufficient to alter endothelial cell behavior both in vitro and in
vivo. Conditioned media from HPV16 E6E7 expressing HFKs as well as from human cervical keratinocytes containing the intact HPV16 were able
to stimulate proliferation and migration of human microvascular endothelial cells. In addition, introduction of the conditioned media into
immunocompetent mice using a Matrigel plug model resulted in a clear angiogenic response. These novel data support the hypothesis that HPV
proteins contribute not only to the uncontrolled keratinocyte growth seen following HPV infection but also to the angiogenic response needed for
tumor formation.
© 2007 Elsevier Inc. All rights reserved.Keywords: Human papillomavirus; Keratinocytes; AngiogenesisIntroduction
To grow, solid tumors must gain access to nutrients and
oxygen via the recruitment of a blood supply, in a process called
angiogenesis (Bouck et al., 1996; Hanahan and Folkman,
1996). Angiogenesis involves a reprogramming of the tran-
scription profile within the tumor cells so that angiogenic in-
ducers predominate over angiogenic inhibitors (the angiogenic
switch). As a lesion progresses, from hyperplasia to dysplasia
and ultimately invasive carcinoma, there is an increase in
microvessel density as well as their proximity to the epithelium
(Dobbs et al., 1997; Guidi et al., 1995; Smith-McCune et al.,⁎ Corresponding author. Fax: +1 317 274 4090.
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doi:10.1016/j.virol.2007.05.0301997). This progressive alteration is seen in human cervical
lesions progressing from dysplasia to invasive carcinoma and is
recapitulated in the human papillomavirus type 16 (HPV16)
transgenic mouse model (Arbeit et al., 1996; Smith-McCune
et al., 1997).
Multiple factors either inhibit or promote angiogenesis
(Bouck et al., 1996; Hanahan and Folkman, 1996). The import-
ance of the proangiogenic factor VEGF in this multistep process
has been described in both the progression of disease in HPV16
transgenic mice and in cervical carcinogenesis in women
(Smith-McCune et al., 1997). Hyperplastic lesions in the mouse
epidermis and mild cervical dysplasia (CINI) in women display
slight increases in the expression of VEGF (by in situ hybrid-
ization) and frequency of microvessels. Dysplastic mouse epi-
dermal lesions and severe cervical dysplasia (CINIII) in women
display more significant increases in the expression of VEGF
Fig. 1. (A) Proliferation of ECs in response to conditioned media from cells
expressing HPV16 proteins. HMVECs were seeded at 5×104 cells/well onto
collagen coated 6-well plates. After serum starvation, conditioned media from
cells transduced with LXSN or L(16E6E7)SN or from HPV16P7AK or CIN612
cells were added overnight and then replaced with media containing 3H-TdR for
5 h. Cells were lysed and incorporated radiolabel counted in a beta-counter. (B)
Migration of ECs in response to conditioned media from cells expressing
HPV16 proteins. Serum-starved HMVECs were plated on a collagen-coated
transwell membrane. Conditioned media were placed in the bottom chamber.
After 3 h, at least 5 high power fields (HPF) of cells on the bottom of the
membrane were counted. For panels A and B the results (average±standard
deviation) are representative of three experiments conducted in triplicate.
Statistical analysis combining the results of three independent experiments
indicated that, in both the proliferation and the migration assays, the difference
between LXSN and 16E6E7 and between C4302 and HPV16P7AK/CIN612 is
significant (**pb0.01).
169W. Chen et al. / Virology 367 (2007) 168–174and frequency of microvessels, with the latter closely apposed
to the altered epithelium.
Human papillomaviruses (HPVs) cause cervical cancer and
some head and neck cancer (Bosch et al., 2002; Herrero et al.,
2003; Munoz et al., 2003; Smith et al., 1998; zur Hausen, 2000).
The virus presumably enters through a break in the epithelium
and initially infects the proliferating epithelial cells (keratino-
cytes). In these cells, the virus undergoes the non-productive
stage of its life cycle where it is maintained as a low copy
number extrachromosomal genome. When the infected cell
moves to the differentiated compartment, infectious virus is
produced. In contrast, at the late stage in the progression of HPV
disease from low-grade squamous intraepithelial lesion (LSIL)
to high-grade SIL to carcinoma in situ, the viral genome
integrates, only expression of the E6 and E7 is maintained and
expression of both is required for cell survival (Butz et al., 2003;
DeFilippis et al., 2003; Hall and Alexander, 2003; Jiang and
Milner, 2002).
The involvement of HPV proteins in the angiogenic switch
and in the vascularization seen in the HPV16 transgenic mice
and the HPV-positive cervical lesions in women has not been
established since the characterization of angiogenesis has been
conducted long after the initial HPV infection (Dobbs et al.,
1997; Guidi et al., 1995; Smith-McCune et al., 1997). This same
limitation exists for experiments monitoring angiogenic factors
in HPV-positive carcinoma cell lines (Bequet-Romero and
Lopez-Ocejo, 2000). Because of the potential effect of HPV
proteins on angiogenic factors, we have designed experiments
to determine whether HPV plays a role in angiogenesis. Speci-
fically, we have used cells at early passage after the introduction
of HPV genes, to test the hypothesis that HPV proteins induce
an angiogenic switch in primary keratinocytes which is
sufficient to render conditioned media from such keratinocytes
angiogenic. We previously analyzed the activity of HPV16 E6
and E7 when expressed as a cassette from a heterologous
retroviral promoter and showed that together they alter the level
of expression of two angiogenic inhibitors, maspin and
thrombospondin-1, and two angiogenic inducers, VEGF and
IL-8 (Toussaint-Smith et al., 2004). Here we show that the
change in keratinocyte phenotype is sufficient to render con-
ditioned media from these cells angiogenic, using both in vitro
and in vivo assays. Further, we have shown this to be the case
not only when E6 and E7 are expressed in a retroviral vector but
also when HPV genes are expressed at physiological levels
from their homologous promoters.
Results
Conditioned media from human foreskin keratinocytes (HFKs)
transduced with HPV16 E6E7 and from cervical keratinocytes
stably transfected with intact HPV16 genomes increase
proliferation and migration of endothelial cells (ECs) in vitro
During angiogenesis, ECs have to penetrate the basement
membrane, migrate, proliferate, and differentiate to form tu-
bules (Hanahan and Folkman, 1996). In vitro proliferation and
migration assays were used to determine whether HPV-inducedchanges in the conditioned media from HFKs transduced with
human papillomavirus type 16 E6 and E7 (HPV16 E6E7) and
passaged for a short time were sufficient to alter EC behavior. In
these experiments, conditioned media from LXSN (retroviral
parent)-transduced HFKs served as a negative control and
VEGF served as a positive control. The conditioned media from
HPV16 E6E7-transduced HFKs induced human microvascular
endothelial cells (HMVECs) to proliferate (Fig. 1A) and to
migrate (Fig. 1B). Statistical analysis combining the results of
three independent experiments indicated that the approximately
two-fold difference in both proliferation and migration between
LXSN and HPV16 E6E7 was significant (pb0.01). The add-
ition of VEGF resulted in a greater than 2- to 3-fold increase in
proliferation and in migration compared to media control (data
not shown).
The experiments thus far indicated that conditioned media
from keratinocytes retrovirally transduced with HPV16 E6E7
and passaged for a short time were sufficient to induce an
alteration in EC behavior. Since natural infection introduces the
entire HPV genome, we determined whether conditioned media
from cells stably transfected with the intact HPV genome and
passaged for a short time (HPV16P7AK) could also induce
ECs to proliferate and migrate. In this case, the viral proteins
170 W. Chen et al. / Virology 367 (2007) 168–174are produced at physiological levels. In these experiments,
conditioned media from HPV31-positive CIN612 cells, a cell
line which was established from a severely dysplastic (CINIII)
cervical biopsy and which is tumorigenic in nude mice
(L. Laimins, personal communication), served as a positive
control and C4302, early passage primary cervical cells, served
as a negative control. The results showed that conditioned
media from HPV16P7AK induced HMVECs to proliferate
(Fig. 1A) and to migrate (Fig. 1B) approximately two-fold
more than media from C4302. Statistical analysis combining
the results of three independent experiments indicated that the
difference between C4302 and HPV16P7AK was significant
(pb0.01). As expected due to their tumorigenic phenotype,
conditioned media from CIN612 cells could also alter EC
behavior.
In mice, conditioned media from keratinocytes transduced with
HPV16 E6E7 or stably transfected with the intact HPV16
genome induce angiogenesis
The magnitude of an angiogenic response depends upon a
complex set of interactions within the microenvironment
(Coussens et al., 1999; Mueller and Fusenig, 2004; Zhu et al.,
2002). To test whether the conditioned media from earlyFig. 2. In vivo angiogenesis assays using conditioned media from keratinocytes ex
Matrigel™) and injected into the ventral groin of mice. Seven days later the mice
hemoglobin was extracted and quantitated. Conditioned media from C4302 and L
respectively. The results shown are representative of three independent experiments, e
measured in one such experiment is shown (**p=≤0.01).passage HPV16 E6E7-transduced human foreskin keratino-
cytes could induce an angiogenic response in vivo, the Matrigel
plug assay was used. Matrigel is derived from a tumor extract
and can be injected into mice to form a plug. This well-
established in vivo assay is a rapid and efficient method to
determine the angiogenic potential of different compounds
placed into the plug prior to injection (Munchhof et al., 2006;
Walker, 2001). The bloody appearance of the Matrigel plug
provides a qualitative representation of the growth of blood
vessels into the plug in response to the angiogenic stimuli. The
assay of hemoglobin extracted from the plug allows quantifica-
tion of the angiogenic response. Matrigel was mixed with
conditioned media from CIN612, HPV16 E6E7-expressing
HFKs or HPV16P7AK and injected into the ventral groin of
immunocompetent mice. Seven days after injection the plug
was removed, photographed, and the hemoglobin was extracted
from the plug and quantified. Conditioned media from CIN612,
16 E6E7-expressing HFKs and HPV16P7AK stimulated an
angiogenic response, quantitated by the hemoglobin extracted
from the Matrigel (Fig. 2). The activity seen with the
conditioned media from the HPV-expressing cells was HPV-
dependent since conditioned media from the control retrovirally
transduced keratinocytes (LXSN) and C4302 did not induce an
angiogenic response (Fig. 2).pressing HPV16 proteins. Conditioned media were mixed with Matrigel (BD
were sacrificed, the Matrigel plug was removed and photographed, and then
XSN serve as negative controls for CIN612 and HPV16P7AK, and 16E6E7,
ach conducted in triplicate. The average±standard deviation for the hemoglobin
171W. Chen et al. / Virology 367 (2007) 168–174Characterization of lysates and conditioned media from HFKs
transduced with HPV16 E6E7 and from cervical keratinocytes
stably transfected with extrachromosal HPV16 genomes
We previously reported that retroviral transduction of HFKs
with HPV16 E6E7 resulted in altered levels of expression of
two angiogenic inhibitors, thrombospondin-1 and maspin, and
two angiogenic inducers, VEGF and IL-8 (Toussaint-Smith et
al., 2004). Here we compared the levels of these four angiogenic
factors in retrovirally transduced HFKs to the levels in cervical
keratinocytes expressing HPV proteins at physiological levels
[from cervical keratinocytes stably transfected with, and main-
taining extrachromosal HPV16 genomes (HPV16P7AK) or
HPV31 (CIN612)].
Semi-quantitative RT-PCR (Fig. 3A) showed that the levels
of transcription of the two angiogenic inhibitors, thrombos-
pondin-1 and maspin, in HFKs retrovirally transduced with
HPV16 E6E7 were slightly but significantly decreased, 74%
and 64%, respectively, relative to HFKs transduced with the
retroviral control. Thrombospondin-1 and maspin mRNA levels
in HPV16P7AKs were 67% and 70%, respectively, of the levels
in C4302. The levels of expression of these angiogenic in-
hibitors were also reduced in CIN612 cells compared to C4302.
In contrast, the levels of the two angiogenic inducers, IL-8 and
VEGF, were increased 1.7- to 2.5-fold in both the retrovirally
transduced cells and those containing the intact HPV genomes,
with the exception that only a 1.3-fold increase in VEGF was
seen in CIN612 cells.
The effect of HPV gene expression on the relative amounts
of these angiogenic factors in the conditioned media was deter-
mined using immunoblots to quantitate thrombospondin-1 and
maspin (Fig. 3B) and ELISAs for IL-8 and VEGF (Fig. 3C).
Levels of thrombospondin-1 were decreased 5-fold in condi-
tioned media from cells expressing HPV proteins and maspin
levels were decreased by at least two-fold, compared to con-
trols. Levels of VEGF in conditioned media from cells express-
ing retrovirally encoded HPV16 E6E7 or the intact HPV16
genome were increased approximately two-fold compared to
controls or four-fold in the case of CIN612 cells (pb0.001).
The levels of IL-8 were increased approximately three-fold
in the retrovirally transduced HFKs and the HPV16P7AK
cells and two-fold in the CIN612 cells, compared to controls
(pb0.01).Fig. 3. (A) Semi-quantitative RT-PCR analysis of thrombospondin-1, maspin,
VEGF, and IL-8. RNA extracts from HFKs transduced with empty vector
(LXSN) or HPV16 E6E7 or from control human cervical keratinocytes (C4302
cells) or cervical keratinocytes containing the intact HPV16 (HPV16P7AK) or
HPV31 (CIN612) were subjected to RT-PCR and analyzed on 2% agarose gels.
GAPDH amplification was used as an internal control. The multiple bands seen
in the VEGF panel represent different isoforms (Kodama et al., 1999). (B)
Western analysis of thrombospondin-1 and maspin in conditioned media from
cells transduced with LXSN or L(16E6E7)SN or from HPV16P7AK or CIN612
cells. Proteins were separated on 10% SDS-PAGE, transferred to nitrocellulose
membrane and probed with antibodies to the indicated proteins. (C) ELISA for
VEGF and IL-8 in conditioned media. The quantity of VEGF and IL-8 was
determined and normalized to total protein in the conditioned media. The results
shown are representative of three independent experiments conducted in tripli-
cate (*pb0.05; **pb0.01).Discussion
The experiments described here were undertaken to deter-
mine whether HPV proteins might contribute to the angiogenic
response seen in the early stages of HPV-mediated disease. To
do so, HPV-expressing HFKs were analyzed early after trans-
duction, when the control cells were still proliferating.
172 W. Chen et al. / Virology 367 (2007) 168–174Similarly, the stably transfected cervical keratinocytes were
analyzed at early passage, prior to the induction of telomerase.
Angiogenesis is a multistep process, beginning at the pre-
malignant stage and involving the progressive enhancement of
the angiogenic switch as a lesion progresses from hyperplasia or
low-grade dysplasia to high-grade dysplasia and carcinoma
(Dobbs et al., 1997; Guidi et al., 1995; Hanahan and Folkman,
1996; Smith-McCune et al., 1997). In the case of cervical
carcinomas and in the HPV16 transgenic mouse model, a
correlation has been made between the upregulation of HPV
E6 and E7 gene expression and the upregulation of VEGF
expression, increases in microvascular density, and close
apposition of neovasculature to the affected tissue (Smith-
McCune et al., 1997). Because high-risk HPV E6 and E7 affect
a number of factors implicated in the regulation of the
angiogenic switch, most notably the tumor suppressors, p53
and pRb, we tested the hypothesis that HPV16 E6 and E7
together would contribute to the angiogenesis required to
sustain tumor growth. We showed that the expression of
HPV16 E6 and E7 in human foreskin keratinocytes caused a
change in the expression of angiogenic factors (Toussaint-
Smith et al., 2004). Here we have shown that the conditioned
media from these retroviral transduced human foreskin
keratinocytes alter EC behavior in vitro and in vivo. In
addition, we have shown that conditioned media from cervical
keratinocytes stably transfected with the intact HPV16 genome
also alter EC behavior in vitro and in vivo. These results
establish that HPV proteins, expressed at physiological levels,
cause a sufficient alteration in the expression of angiogenic
factors in keratinocytes to affect EC behavior.
Different cell lineages within the tumor microenvironment,
not just the tumor-initiating cell itself, secrete growth factors,
which combine to recruit ECs from the local vasculature as well
as from the bone marrow to the tumor (Orimo et al., 2005). Thus
stromal fibroblasts and mast cells have also been documented to
be contributors to the angiogenic process (Bhowmick et al.,
2004; Coussens et al., 1999). Data described here are consistent
with an effect of the microenvironment on amplification of the
HPV-initiated signal. There is a greater angiogenic response to
the conditioned media from HPV-expressing keratinocytes in
the Matrigel plug assay in vivo (at least a 10-fold stimulation,
Fig. 2) than in either the proliferation or migration assay in vitro
(approximately two-fold stimulation, Fig. 1). In contrast to the
in vivo assay, only endothelial cells are exposed to the media
in the in vitro assays.
The angiogenic response requires that the levels of angio-
genic inducers increase and/or the level of angiogenic inhibitors
decrease (Bouck et al., 1996). Four angiogenic factors were
analyzed in this study. They were chosen because VEGF, IL-8,
and thrombospondin-1 levels had been reported to be altered in
cervical carcinomas and cervical carcinoma cell lines (Bequet-
Romero and Lopez-Ocejo, 2000; Dobbs et al., 1997; Guidi et
al., 1995; Smith-McCune et al., 1997); a limited microarray
analysis showed altered levels of expression of VEGF, maspin,
and thrombospondin-1 RNA in HPV16 E6E7-transduced HFKs
(Toussaint-Smith et al., 2004); and IL-8 was additionally found
to be upregulated in oral squamous cell carcinomas (Lingen etal., 1996) and affected by HPV gene expression (Huang and
McCance, 2002; Nees et al., 2001; Toussaint-Smith et al.,
2004). Further experiments will be needed to determine whe-
ther alterations in one or more of these factors, or yet to be
defined factors, are responsible for the HPV-mediated angio-
genic switch seen in keratinocytes which subsequently affects
ECs.
Materials and methods
Cell culture and collection of conditioned media
Pools of primary human foreskin keratinocytes were pre-
pared and infected with parental vector control virus LXSN,
or recombinant retrovirus L(16E6E7)SN (ATCC) as pre-
viously described (Toussaint-Smith et al., 2004). Following
selection, the cells were expanded in complete E media on
mitomycin-treated J2-3T3 feeder cells (Wu et al., 1982). For
collection of conditioned media, 2.5×106 cells (at passage 3)
were plated in E media in 10-cm plates with 2×105 feeder
cells for 24 h. Cells were then starved for 4 h in 4 ml of basal
E media (3 parts DMEM, 1 part Ham's F-12 with 100 U/ml of
penicillin and 100 μg/ml of streptomycin) before switching to
8 ml of the same media and conditioned media were harvested
24 h later. In parallel, cells were lysed and RNA and protein
were collected. HPV16P7AK cells (originally called C66 C1F
P7) are early passage cervical keratinocytes stably transfected
with and maintaining extrachomosomal HPV16, from A.
Klingelhutz (U. Iowa) (Sprague et al., 2002). The cells are not
tumorigenic (Berger et al., 2006). C4302 are primary cervical
keratinocytes. CIN612 cells contained episomal HPV31.
HPV16P7AK, C4302, and CIN612 cells were maintained in
E media on feeder cells and conditioned media were harvested
as described for the retrovirally transduced HFKs. Condi-
tioned media were quick frozen in an alcohol/dry ice bath and
stored at −80 °C. HMVECs (Cambrex, Walkersville, MD)
were maintained in complete EGM-2 supplemented with 10%
FBS in tissue culture flasks precoated with type I rat tail
collagen (BD Biosciences). Experiments were done at passage
5 to 8.
RNA isolation and semi-quantitative reverse transcription
(RT)-PCR analysis
Total RNA was prepared using RNeasy Minikit (Qiagen,
Valencia, CA, USA) and contaminating DNA was removed by
digestion with the RNase-Free DNase Set (Qiagen). 0.5 μg of
RNA was reverse-transcribed and amplified using Superscript
Onestep RT-PCR kit (Invitrogen) and primers for thrombos-
pondin-1, maspin and GAPDH (Toussaint-Smith et al., 2004),
IL-8 (Seo et al., 2004), and VEGF (Kodama et al., 1999).
Reactions were carried out with 52 °C annealing temperature
and stopped at 22 cycles for GAPDH, 28 cycles for IL-8 and
26 cycles for all others. The RT-PCR products were visualized
on a 2% agarose gel with ethidium bromide staining, pictures
were analyzed with Quantity one software (Bio-Rad, Hercules,
CA, USA). Arbitrary density units were adjusted based on
173W. Chen et al. / Virology 367 (2007) 168–174GAPDH and calculated by setting each negative control to
one.
ELISA analysis
Conditioned media were analyzed in triplicate using human
CXCL-8 (IL-8) and VEGF Quantikine ELISA kits purchased
from R&D systems (Minneapolis, MN, USA).
Western blot analysis
Proteins in conditioned media, concentrated using an
Amicon ultra centrifugal devise filter (5000 MWCO), were
separated by 10% SDS-PAGE, transferred to nitrocellulose
membranes (Bio-Rad, Hercules, CA, USA), and probed with
antibodies to GAPDH (MAB374, Chemicon, Temecula, CA,
USA), maspin (554292, BD Biosciences, Pharmingen, San
Diego, CA, USA), and thrombospondin (MS-1066, Lab Vision,
Fremont, CA, USA). Quantity one software was used for densi-
tometry analysis. Arbitrary density units were calculated as
described for RT-PCR.
In vitro proliferation assay
Cell proliferation was determined by [3H] thymidine
incorporation as previously described (Munchhof et al., 2006).
HMVECs were plated in collagen-coated 6-well plates (BD
Biosciences, Bedford, MA, USA) at 5×104 cells/well and were
deprived of serum. Conditionedmedia were then added for 8 h in
a 37 °C, 5%CO2, humidified incubator. Cells were pulse labeled
with 1 μCi/ml of [3H] thymidine (Perkin-Elmer Life Sciences
Products, Boston, MA, USA) for 5 h, washed, lysed with 0.1 N
NaOH and measured with a beta counter (Beckman Coulter Inc.,
Fullerton, CA, USA). Assays were performed in triplicate.
In vitro migration assay
Migration assays were performed as previously described
(Munchhof et al., 2006) with minor modifications. Transwell
cell culture inserts (BDBiosciences, Bedford, MA, USA) coated
with collagen were placed into the lower chamber containing
600 μl conditioned media. 5×104 Cells/Well of serum-deprived
HMVECs were placed on top of the insert and incubated for 3 h.
Non-migrating cells were removed using a cotton swab, and
migrating cells were fixed and stained with Diff-quick kit
(Invitrogen). The average number of migrated cells was counted
with an inverted microscope at 20× magnification. 25 ng/ml of
VEGF with 0.1% BSAwas also used as a positive control (data
not shown). Assays were performed in triplicate.
In vivo Matrigel plug assay
C57BL/6.129 or C57BL/6 mice were used in accordance
with a protocol approved by the Indiana University Animal Use
and Care Committee. 10 mg/ml of Matrigel (BD Biosciences)
was mixed with 60 U/ml heparin (Sigma) and 90 μg of con-
ditioned media on ice before injection. Matrigel (300 μl) wasinjected subcutaneously into the murine groin. After 7 days,
plugs were harvested, photographed and assayed for total hemo-
globin using a hemoglobin assay kit (Pointe Scientific, Lincoln
Park, MI, USA). 600 ng/ml bFGF (Peprotech, Rocky Hill, NJ,
USA) was also used as a positive control (data not shown).
Statistical analysis
Student's two-tailed t-test was used for statistical analysis.
pb0.05 was considered significant.
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